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Abstract
Context—In 2009, the Centers for Disease Control and Prevention completed migration of all 59 
surveillance project areas (PAs) from the case-based HIV/AIDS Reporting System to the 
document-based Enhanced HIV/AIDS Reporting System.
Objectives—We conducted a PA-level assessment of Enhanced HIV/AIDS Reporting System 
process and outcome standards for HIV infection cases.
Design—Process standards were reported by PAs and outcome standards were calculated using 
standardized Centers for Disease Control and Prevention SAS code.
Setting—A total of 59 PAs including 50 US states, the District of Columbia, 6 separately funded 
cities (Chicago, Houston, Los Angeles County, New York City, Philadelphia, and San Francisco), 
and 2 territories (Puerto Rico and the Virgin Islands).
Participants—Cases diagnosed or reported to the PA surveillance system between January 1, 
2011, and December 31, 2011, using data collected through December 2012.
Main Outcome Measures—Process standards for death ascertainment and intra- and interstate 
case de-duplication; outcome standards for completeness and timeliness of case reporting, data 
quality, intrastate duplication rate, risk factor ascertainment, and completeness of initial CD4 and 
viral load reporting.
Results—Fifty-five of 59 PAs (93%) reported linking cases to state vital records death 
certificates during 2012, 76% to the Social Security Death Master File, and 59% to the National 
Death Index. Seventy percent completed monthly intrastate, and 63% completed semiannual 
interstate de-duplication. Eighty-three percent met the 85% or more case ascertainment standard, 
and 92% met the 66% or more timeliness standard; 75% met the 97% or more data quality 
standard; all PAs met the 5% or less intrastate duplication rate; 41% met the 85% or more risk 
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factor ascertainment standard; 90% met the 50% or more standard for initial CD4; and 93% met 
the same standard for viral load reporting. Overall, 7% of PAs met all 11 process and outcome 
standards.
Conclusions—Findings support the need for continued improvement in HIV surveillance 
activities and monitoring of system outcomes.
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In 2012, the US Centers for Disease Control and Prevention (CDC) released its vision for 
21st-century public health surveillance and assessed the challenges associated with 
collecting and interpreting high-quality public health information to support prevention 
practices.1 Among the topics was the impact on data collection strategies of emerging 
technologies, barriers to data sharing, and the analytic challenges associated with linking 
multiple unique datasets. The CDC’s population-based National Human Immunodeficiency 
Virus (HIV) Surveillance System (NHSS) is affected by these challenges at different levels 
across individually funded project areas (PAs) and within multiple components of the 
system that include case level, incidence, perinatal, and molecular elements. The use of 
NHSS data to guide the allocation of HIV-prevention funding, its increasing use as a 
mechanism for prevention program development and assessment, and its use as a driver for 
public health action clearly indicate the need for system evaluation. This article summarizes 
an evaluation of the key process and outcome measures for HIV infection case-level 
surveillance at the national, state, local, and territorial levels and serves as a model for 
ongoing state and national evaluation.
The CDC began surveillance of AIDS in June 1981 and by late 1985 established the AIDS 
Reporting System (ARS) data collection tool at the local and state level. In August 1993, the 
CDC replaced ARS with the HIV/AIDS Reporting system (HARS), so PAs with integrated 
name-based reporting could maintain and report cases of HIV infection to the CDC 
irrespective of stage of disease. Personal identifiers such as social security number and name 
are not sent to the CDC for purposes of confidentiality. Both ARS and HARS were case-
based systems (1 record per person), with limited numbers of variables available (eg, only 
20 CD4 and 9 viral load (VL) tests could be entered) and no mechanism for capturing the 
source from which data originated. These limitations led to the development of the 
Enhanced HIV/AIDS Reporting System (eHARS), a document-based system that allows for 
an unlimited number of surveillance reports per person to populate demographic, risk factor, 
clinical care, laboratory result, and mortality variables. All 59 PAs completed migration to 
eHARS by July 2009, making the 2011 diagnosis year an optimal time for evaluation of data 
used to inform and equitably distribute federal HIV infection prevention and care funding 
across the United States.
Methods
Guidance from the CDC on evaluation of surveillance systems was issued in 2001 and 
recommended the assessment of 9 basic attributes: simplicity; flexibility; data quality; 
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acceptability; sensitivity; predictive value positive; representativeness; timeliness; and 
stability.2 Prior publication of Guidance for National HIV Case Surveillance by the CDC in 
collaboration with the Council of State and Territorial Epidemiologists included minimum 
performance standards for 3 of those attributes: sensitivity; timeliness; and data quality.3 
Operationalization of these attributes for the specific purpose of evaluating HIV case 
surveillance resulted in 3 process standards and 8 outcome standards.4 Minimum process 
standards require (1) annual linkage of HIV infection case reports with state vital statistics 
death certificates to support death ascertainment; (2) monthly intrastate de-duplication of 
case records; and (3) semiannual interstate de-duplication of case records requiring 
collaboration with other PAs.5–7 Outcome standards include quantitative measures of 
completeness and timeliness of case reporting, data quality, intrastate case duplication rate, 
risk factor ascertainment, and reporting of CD4 (count or percent) and VL test results 
measured within 3 months following initial diagnosis of HIV infection (hereafter referred to 
as the initial CD4 and VL), and the publication of an HIV infection surveillance report at the 
PA level (Table 1). Standardization of these measures across PAs enables CDC to provide 
performance feedback and improve the quality of NHSS data.
We evaluated the extent to which the PAs achieved the 3 process and 8 outcome standards 
for calendar year 2011 (ie, all cases of HIV infection either newly diagnosed or reported, 
based on the specific measure, between January 1, 2011, and December 31, 2011). Data 
reported to the PAs through the end of December 2012 were used for the evaluation to allow 
at least 12 months for reporting delays, case investigations, and data processing. Evaluation 
of each PA-included only cases who resided in that PA at the time of HIV infection 
diagnosis. The CDC provided standardized SAS (version 9.3) programs for PA application 
to ensure comparability of results while process measures were based on PA self-report. 
Project areas are required to submit their evaluation results to the CDC as a component of 
their annual progress reports (APR).
This study is exempt from institutional review board approval, as it reports only summary-
level public health surveillance system evaluation data.
Process standards
The APRs received in March 2013 for the 2011 diagnosis/report year were reviewed for 
confirmation that 3 process standards were met. Death ascertainment requires evidence of no 
less than annual linkage of HIV infection case reports with state vital statistics death 
certificates,5 the Social Security Death Master File,8 and the National Death Index.9 In 
addition, to ensure the accuracy of case counts at the state and national levels, identification 
and resolution of intrastate duplicate cases are required monthly and interstate duplicate 
cases semiannually. Potential intrastate duplicate pairs are identified by matching last name 
soundex,10 date of birth, sex at birth, and country and state of residence at HIV or AIDS 
diagnosis within each PA and manually researched to determine whether they are duplicate 
records for a single person. Potential interstate duplicate pairs (ie, reported by different PAs) 
are identified by the CDC by matching on last name soundex, date of birth, and sex at birth. 
Newly reported diagnoses of HIV infection during the previous 6 months are compared with 
the national database, and potential duplicates are provided to each PA in a Routine 
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Interstate Duplicate Review report. As with suspected intrastate pairs, all interstate pairs are 
researched and updated in the surveillance system to reflect the same person or different 
persons.
Completeness and timeliness of case reporting
Thirty-nine PAs used a 3-source log-linear capture-recapture model11 to estimate the 
completeness of reporting of persons newly diagnosed with HIV infection in 2011 and 
reported to the PA surveillance system by the end of 2012. The 3 sources, health care 
provider, laboratory, and other (eg, other public health databases such as sexually 
transmitted disease or hepatitis surveillance systems), represent the most common sources 
from which a diagnosis of HIV infection may be reported to the surveillance system. If “1” 
represents being reported by a source and “0” otherwise, each new diagnosis in 2011 was 
classified into 1 of the 7 cells 100, 010, 001, 110, 101, 011, and 111. On the basis of the 
observed frequency count in each of the 7 cells, the log-linear models estimated the number 
of new diagnoses in 2011 that were not reported by any of the 3 sources by the end of 2012, 
f̑000. The estimated completeness of reporting of persons newly diagnosed in 2011 by the 
end of 2012 was the sum of the 7 frequency counts divided by the sum of the 7 frequency 
counts plus f̑000. A more detailed description of using the 3-source capture-recapture method 
to evaluate the completeness of reporting HIV infection diagnoses can be found 
elsewhere.11 For these PAs, the estimated timeliness of reporting was calculated by dividing 
the number of HIV diagnoses in 2011 reported within 6 months following diagnosis among 
those who had been reported by the end of 2012 by the sum of the 7 frequency counts plus 
f̑000.
For the remaining 20 PAs, an alternative approach for measuring the completeness of 
reporting was used because, by the end of 2012, these areas had reported fewer than 30 
diagnoses of HIV infection in 2011 or at least 1 of the 3 sources had reported less than 20% 
of the total number of HIV diagnoses in 2011.
The analytic method used examines the year of HIV diagnosis among persons newly 
reported to the PA from 2008 to 2012 and estimates the probability of being reported within 
12 months after the diagnosis year using conditional probabilities that are estimated on the 
basis of historical data. The method assumes that all diagnoses were reported within 4 years 
after the diagnosis year. For these PAs, the estimated timeliness was derived as the product 
between the estimated conditional probability of being reported within 6 months following 
diagnosis, given that the diagnosis was reported within 1 year after the diagnosis year and 
the estimated probability of being reported within 1 year after the diagnosis year.
With significant level set at 0.10, a PA was considered as meeting the 85% or more 
completeness standard if the low bound of the 90% confidence interval (CI) for 
completeness was at least 85% and was not considered to have met the standard if the upper 
bound of the 90% CI fell below 85%. The PAs meeting neither of these lower- or upper-
bound criteria were classified as undetermined. Similarly, a PA was considered as meeting 
the 66% or more timeliness standard if the lower bound of the 90% CI for time liness was at 
least 66% and not meeting the standard if the upper bound of the 90% CI fell below 66%. 
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The PAs meeting neither of these lower- or upper-bound criteria were classified as 
undetermined.
Data quality
There are approximately 200 built-in data entry edit checks within eHARS to identify data 
problems and protect data integrity. To report a person to the NHSS, the CDC requires that 
(1) the person must meet the surveillance case definition of HIV infection,12 (2) there is no 
missing value in the required data elements, and (3) the case record has passed all real-time 
automated data entry checks in eHARS. For this report, data quality was measured by the 
percentage of cases that met these criteria by the end of 2012 among cases newly diagnosed 
in 2011. The PA was considered as having met the data quality outcome standard if the 
percentage was at least 97%.
Intrastate case duplication rate
Unless indicated by the PA as “Different from” (ie, different persons) in the surveillance 
system, the CDC considers cases as duplicates if (1) they match on last name soundex, date 
of birth, sex at birth, and country and state of residence at HIV or AIDS diagnosis or (2) 
they do not match on the abovementioned variables but the PA had indicated that the cases 
were the “Same as” (ie, the same person). Duplicate status data (ie, “Different from” or 
“Same as”) reported through the end of 2012 were used to estimate the intrastate case 
duplication rate among HIV cases reported to the PA through the end of 2011. The 
estimated intrastate case duplication rate was calculated by dividing the number of pairs of 
cases that satisfied criterion 1 or 2 by the cumulative number of HIV cases reported through 
December 31, 2011. The PA was considered to have met the duplication outcome standard if 
the rate was no more than 5%.
Risk factor ascertainment
Risk factor ascertainment for an HIV case is considered complete if, by 12 months after the 
report year, there is sufficient risk factor information to classify the case into a known 
transmission category.5 In general, a female HIV case with no history of injection drug use 
or any other risk factors for HIV infection, but who had sexual contact with a male whose 
HIV serostatus and risk factor for HIV infection are unknown, is classified as a case with no 
identified risk factor in the transmission category hierarchy.5 However, for the purpose of 
this evaluation, such a case was classified as Female Presumed Heterosexual Contact and 
regarded as having a known transmission category. Completeness of risk factor 
ascertainment was measured by the percentage of HIV cases reported in 2011 that had a 
known transmission category by the end of 2012, and the PA was considered to have met the 
completeness outcome standard for risk factor ascertainment if the percentage was at least 
85%.
Initial CD4 and VL reporting
Evaluations of the completeness of reporting of initial CD4 (count or percent) and VL test 
results were restricted to adults and adolescents (diagnosed at the age of ≥13 years). In the 
evaluation, only VL tests that produced a result in absolute number of HIV RNA copies per 
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milliliter of blood or with an interpretation of below limit, within limit, or above limit were 
considered. Moreover, CD4 and VL test results without a specimen collection date were 
excluded from consideration for this analysis. Completeness was measured by the 
percentage of adults and adolescents newly diagnosed with HIV infection in 2011 who had 
an initial CD4 or VL test result by the end of 2012. The PA was considered to have met the 
completeness outcome standard for initial CD4 and initial VL if the percentages were at 
least 50%.
Data dissemination
As a component of their APR, each PA was required to provide an electronic link to or, a 
copy of, a surveillance report published in 2012. The mechanism for release of HIV 
infection information varies and is determined by PAs.
Results
Process standards
Fifty-five of the 59 PAs (93%) reported linking case data to their state vital statistics death 
certificates during 2012 (Colorado, Idaho, Maine, and Vermont did not meet this standard) 
(Table 2). Of the 55 PAs that completed a linkage, 2 linked case data to deaths that occurred 
through 2009, 5 linked deaths through 2010, and the remaining 48 linked deaths that 
occurred through 2011, with 5 beginning to link deaths that occurred in 2012. In addition, 45 
PAs (76%) linked case data to the Social Security Death Master File and 35 PAs (59%) to 
the National Death Index, although the data years linked for these 2 sources is not reported.
Monthly intrastate de-duplication was completed by 41 PAs (70%) and 16 other PAs (27%) 
completed intrastate de-duplication at least once per year but not monthly as required (data 
not shown). Semiannual interstate de-duplication was not conducted by 3 of the separately 
funded cities (Chicago, Houston, and Philadelphia), as it was completed at the state level. Of 
the remaining 56 PAs, 35 (63%) resolved all interstate duplicate cases identified by the CDC 
and 10 PAs (18%) resolved a portion, but not all duplicate cases reported in 2011.
Outcome standards
Of the 39 PAs using the 3-source log-linear capture-recapture model for estimating 
completeness of case reporting 35 (90%) met the 85% or more standard, 2 (5%) did not meet 
the standard, and 2 (5%) were undetermined on the basis of broad CIs. Thirty-seven PAs of 
the 39 (95%) met the 66% or more timeliness standard and the remaining 2 were 
undetermined (see Supplemental Digital Content Table 4, available at: http://links.lww.com/
JPHMP/A68).
Of the 20 PAs that used the reporting delay model, 14 (70%) met the completeness standard, 
2 (10%) fell below the standard, and 4 (20%) were undetermined. Seventeen (85%) met the 
timeliness standard, 1 (5%) fell below, and 2 (10%) were undetermined.
Forty-four of the 59 PAs (75%) met the 97% data quality standard. Fourteen PAs (24%) 
achieved 100% compliance, and only 2 PAs fell below 90% (New York excluding New 
York City 80% and Maryland 78%).
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Fifty-six PAs reported rates for intrastate duplication, all of which met the standard of 5% or 
less (range, 0%–1.0%) duplicates by December 31, 2012. Three separately funded cities/
counties (Chicago, Houston, and Philadelphia) did not report PA-specific percentages, as 
their duplicate review is conducted and reported at the statewide level (see Supplemental 
Digital Content Table 4, available at: http://links.lww.com/JPHMP/A68).
Only 24 of the 59 PAs (41%) met the risk factor ascertainment standard requiring 85% or 
more of the cases reported in 2011 to have a known transmission category by December 31, 
2012 (range, 37% in Maryland to 100% in multiple states). Seventy-five percent of PAs 
achieved 75% or more and Maryland and Georgia fell below 60% (37% and 57%, 
respectively) (Table 3).
Fifty-three of the 59 PAs (90%) met the requirement that 50% or more of newly diagnosed 
cases in 2011, aged 13 years or older, have an initial CD4 count or percentage by December 
2012 (range, 38% in Tennessee to 100% in North Dakota). Similarly, 55 of the 59 PAs 
(93%) met the same standard for reporting of initial VL (range, 32% in Oklahoma to 100% 
in North Dakota). Finally, 56 of the 59 PAs (95%) produced an annual surveillance report 
during 2012. Montana, Nebraska, and Vermont did not meet this standard in the required 
time frame.
In summary, of the 11 standard process and outcome measures evaluated, 4 of the 59 PAs 
(7%) met all 11 standards, 18 (31%) met 10 standards, 17 (29%) met 9 standards, and the 
remaining 20 (34%)met 8 standards or fewer. The PAs that met all 11 standards were 
Florida, Iowa, Missouri, and the city of Philadelphia.
Lessons Learned
We evaluated the performance of the NHSS for the 2011 report year. To our knowledge, the 
current study is the first comprehensive evaluation of performance standards for HIV 
surveillance systems.3 Data summarized in this report are provided by PAs using CDC-
developed standardized outcome evaluation software and analytic programs.
At 12 months after the end of the diagnosis year (ie, December 31, 2012), 83% of the PAs 
met the case ascertainment criteria. Three of the 10 PAs that did not meet the case finding 
standard, or for whom the result was indeterminate, also failed to meet 5 of the other 
outcome standards, suggesting PAs’ systemic challenges with data collection. Another 5 
PAs failed 1 or no other measures, suggesting that improvements in case finding are needed.
Data quality was measured by ensuring that each HIV case has valid values for all required 
variables and passed approximately 200 real-time data entry checks. Seventy-five percent of 
PAs met or exceeded the 97% standard. Both PA assessment and national assessment of 
individual variable collectability and usefulness should be an ongoing activity.
Removal of duplicate records from the surveillance system is critical to establishing accurate 
national, state, and local estimates of HIV infection and AIDS for prevention planning and 
resource allocation, including for the use of diagnosis data by the Health Resources Services 
Administration (HRSA) to equitably allocate federal Ryan White Care Act prevention 
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funding.13,14 A prior assessment of duplicate records in the national surveillance system 
found that 4.5% of cases were duplicates and recommended that the CDC develop reports to 
facilitate both intra- and interstate de-duplication efforts15 on a routine basis. The CDC 
implemented the recommendation, and the current study notes a marked improvement in 
identification and resolution of duplicate records. All PAs met the intrastate duplicate record 
goal of 5% or less, with only 1 PA exceeding 0.9%. This suggests that the intrastate 
duplication standard could be reasonably decreased to less than 1%. Since PAs do not have 
access to other PA data, a report of potential interstate duplicate records is provided by the 
CDC semiannually. Processing the duplicates requires telephone contact with other PAs to 
confirm or reject the records as duplicates; a noted barrier to accomplishing de-duplication is 
establishing that contact. Facilitating a more efficient communication process could improve 
the resolution of interstate duplicates.
Risk factor ascertainment was the most difficult measure to meet, with only 41% of PAs 
achieving the 85% standard (Table 3). A previous review of the APRs submitted by PAs not 
achieving at least 70% suggested a number of potential strategies for increasing risk factor 
ascertainment. Among those strategies were (1) improving the percentage of reports that are 
received electronically, freeing up staff to pursue risk factor data; (2) linking to clinics, 
community service programs, counseling centers, and other surveillance programs to share 
data; (3) and assigning local rather than state health department staff to develop provider 
relationships in their areas and provide training. Some of these strategies are currently in 
place in PAs that met the risk factor ascertainment standard. Sharing strategies between PAs 
and continued development of electronic data sharing capabilities may help facilitate data 
collection in less successful PAs.
The presence of an initial CD4 and VL result exceeded the 50% standard in 86% of the PAs. 
Of the 8 PAs not meeting either the initial CD4 or VL standard, 2 failed both measures 
(Maine and Oklahoma). Maine had laws or regulations that mandate the reporting of all 
values of CD4 and VL results since before January 1, 2010, suggesting that a systemic 
barrier for capturing laboratory test results, whereas Oklahoma laws required only the 
reporting of CD4 results of fewer than 500 count or percentage and all VL results regardless 
of result. Six of the 8 PAs failed only 1 of the 2 laboratory requirements, perhaps suggesting 
differences in physician testing patterns or laboratory reporting laws. Idaho reported the 
largest differential, with 40% reporting initial CD4 counts or percentages and 78% reporting 
initial VL results. State regulations in Idaho in 2011 required that only CD4 counts fewer 
than 200 or CD4 percent less than 14%, and only detectable VL results were reportable.
Limitations
This report is subject to at least 3 limitations. First, not all PAs submitted their evaluation 
reports at the required 12-month interval. A total of 20 months of additional reporting time 
was encountered. Forty-six of the 59 PAs (78%) reported their evaluation results as of 12 
months after 2011 as required by CDC evaluation standards. Nine PAs (Connecticut, 
Hawaii, Mississippi, Nebraska, New Hampshire, Oregon, Philadelphia, South Carolina, and 
San Francisco) were delayed until 13 months, 2 (District of Columbia and South Dakota) 
until 14 months, 1 (Arkansas) until 15 months, and 1 (North Dakota) until 16 months after 
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2011. Because of the additional time for data collection, PAs that allowed 13 or more 
months of data collection may have inflated results compared with those that measured at 
the required 12-month interval.
Second, the capture-recapture method for evaluating case reporting completeness and 
timeliness is subject to under- and overestimation due, in part, to dependence between data 
sources, data accuracy, source completeness, and false-positive or -negative matching of 
multiple records.11,16 Inaccurate case estimates may result in misallocation of federal funds 
for prevention and care programs and invalid assessment of the effectiveness of public 
health or prevention programs.
Third, the completeness of initial CD4 and VL test results are dependent on many factors, 
including individual state laws that both mandate and prohibit reporting specific types of test 
results. As of 2012, more than 20 PAs did not require reporting of all CD4 and VL test 
results. In addition, physician testing practices and laboratory cooperation may vary and the 
availability of electronic laboratory reporting and delays in data entry by PAs may impact 
completion of CD4 and VL reporting outcomes.
Conclusion
These analyses demonstrate the importance of standardized evaluation of the national HIV 
surveillance system in identifying strengths and opportunities among multiple PAs to target 
process and system improvements. A large number of PAs exceeded the current 
performance standards, suggesting that a reevaluation of data standards is warranted. In 
addition, a high percentage of PAs struggled with 1 or 2 aspects of data collection, 
suggesting that mentoring among PAs may be beneficial. Other PAs struggled with nearly 
every measure, indicting the need for highly structured technical assistance. Annual 
assessment of all 11 criteria in each PA will serve as a guide for ensuring the highest-quality 
data for HIV infection monitoring and allocation of prevention funding that could be used 
for development, implementation, and evaluation of relevant interventions and programs.
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TABLE 1
Outcome Standardsa for HIV Case Surveillance in the United States
Outcome Standard Definition
Completeness and timeliness of 
case reporting
≥85% of the expected number of cases for a diagnosis year are reported and ≥66% are reported within 6 
mo after diagnosis, assessed at 12 mo after the diagnosis year
Data quality ≥97% of cases for a diagnosis year pass all standard data edits checks, assessed at 12 mo after the diagnosis 
year
Intrastate duplicates ≤5% duplicate cases, assessed at 12 mo after the report year
Risk factor ascertainment ≥85% of cases for a report year have sufficient risk factor information to be classified into a known HIV 
transmission category, assessed at 12 mo after the report year
CD4 reporting ≥50% of cases 13 y or older for a diagnosis year have an initial CD4 test result, assessed at 12 mo after the 
diagnosis year
Viral load reporting ≥50% of cases 13 y or older for a diagnosis year have an initial viral load test result, assessed at 12 mo 
after the diagnosis year
Data dissemination Annual HIV infection surveillance report published by the project area
Abbreviation: HIV, human immunodeficiency virus.
a
Standards listed are requirements that, when met, indicate a fully functioning surveillance system with high-quality data.
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TABLE 2
Number and Percentage of Project Areas by Year of Their Last Vital Statistics Linkage to eHARS
Project Area







Florida, Indiana, Kentucky, Missouri, American Virgin Islands 2012a 5 8.5
Alabama, Alaska, Arizona, Arkansas, Chicago, Connecticut, Delaware, District of 
Columbia, Georgia, Hawaii, Houston, Illinois, Iowa, Kansas, Louisiana, Maryland, 
Massachusetts, Minnesota, Mississippi, Montana, Nebraska, Nevada, New 
Hampshire, New Jersey, New Mexico, New York, New York City, North Carolina, 
North Dakota, Ohio, Oklahoma, Philadelphia, Rhode Island, South Carolina, South 
Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, 
Wyoming
2011 43 72.9
California, Michigan, Pennsylvania, Puerto Rico, San Francisco 2010 5 8.5
Los Angeles, Oregon 2009 2 3.4
Colorado, Idaho, Maine, Vermont No linkage 4 6.8
Abbreviation: eHARS, Enhanced HIV/AIDS Reporting System.
a
State began loading early 2012 vital statistics, but data were not complete.
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